Home » Veterinary Regenerative Medicine Market

Veterinary Regenerative Medicine Market By Therapy Type (Cell-Based Therapies, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Tissue Engineering); By Application Areas (Orthopedic Disorders, Dental Disorders, Soft Tissue Injuries, Neurological Disorders); By End-User (Veterinary Hospitals and Clinics, Research Institutions, Biotechnology Companies); By Region – Growth, Future Prospects & Competitive Analysis, 2023 -2030

Price: $4999

Published: | Report ID: 32141 | Report Format : PDF

Market Insights

  • The global demand for Veterinary Regenerative Medicine was valued at USD 284.5 million in 2022 and is expected to reach USD 800.2 Million in 2030, growing at a CAGR of 13.80% between 2023 and 2030.
  • The stem cells sector had the most revenue share in 2022, and the Platelet-Rich Plasma (PRP) Therapy segment is predicted to grow at the fastest CAGR.
  • The orthopedic disorders category earns the most money in the veterinary regenerative medicine market.
  • In 2022, veterinary hospitals and clinics dominated the end-use category, while research institutes are expected to grow at the quickest CAGR in the near future.
  • North America had a revenue share of more than 35% in 2022, and Asia Pacific is expected to increase at the fastest rate over the projected period.
  • Stem cell therapy is the technology driving market expansion.
  • Affordability and accessibility issues are impeding market growth.

Veterinary Regenerative Medicine Market

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Executive Summary

Market Definition

Veterinary Regenerative Medicine Market refers to the market for regenerative medicines and treatments specifically created for animals, with an emphasis on their healing and regeneration abilities. It entails the use of stem cells, growth factors, and other biological materials to stimulate tissue repair, reduce inflammation, and improve overall healing in animals. Veterinary regenerative medicine has the potential to cure a variety of problems in animals, including musculoskeletal injuries, osteoarthritis, and other degenerative disorders. This burgeoning market promises to provide creative and effective solutions to promote animal health and well-being.

Market Overview

It is anticipated that between 2023 and 2030, the worldwide Veterinary Regenerative Medicine Market will expand at a compound annual growth rate (CAGR) of 13.80%. From USD 284.5 million in 2022, the market is projected to be worth USD 800.2 million by 2030.

Veterinary regenerative medicine is a specialty of medicine that uses cutting-edge procedures to help animals regenerate injured tissues and organs. It entails employing stem cells, growth factors, and other biomaterials to enhance the body’s natural healing processes and encourage the development of new tissues. Rising pet expenditures, regenerative medicine research and development, the prevalence of acute and chronic disorders in pets, and actions by key stakeholders all contribute to the rise. For instance, Boehringer Ingelheim bought Global Stem Cell Technology (GST), a Belgian veterinary biotech startup, in July 2020 to expand its stem cell capabilities in veterinary medicine.

Regenerative medicine therapy for treating many illness situations has grown in favour in both human and veterinary medicine. Animals are given cells and tissues, such as live cells, serum, or bone, to replace diseased or damaged tissues or organs in the rapidly emerging field of veterinary regenerative medicine. Recet research in companion animals have shown that it is beneficial in treating a variety of orthopedic ailments, including osteoarthritis and soft tissue injuries. Regenerative medicine is becoming more popular as an alternative to surgical, pharmacological, and rehabilitation therapy, or as part of a multimodal strategy to treating a condition or damage.

Segmentation by Valve Type

  • In 2022, the stem cells segment had the biggest revenue share. Stem cells are becoming increasingly popular in the field of regenerative medicine. Regenerative cell therapies have the ability to repair and replace injured tissues and organs. Tissue regeneration based on cellular therapy may help patients by lowering death and infection rates. Businesses and academic institutions are collaborating to develop new therapy alternatives for the illness.
  • During the projection period, the Platelet-Rich Plasma (PRP) Therapy segment is expected to increase at the quickest CAGR.

  Segmentation by Application

  • The orthopaedics disorders segment controls the majority of the income in the veterinary regenerative medicine market. The increased incidence of orthopaedic disorders, such as chronic degenerative disease, the aging workforce, and the increasing number of traffic accidents all contribute to market expansion. The development of modern orthopedic devices is expected to significantly reduce the cost of existing ones. This contributes to the latter’s increased popularity in emerging economies.

Segmentation by End-User

  • In 2022, the veterinary hospitals and clinics segment dominated the end-use segment. A significant number of veterinary clinics and hospitals, a high footfall of patients received at these facilities, and expanding pet health concerns are all factors contributing to the segment’s high share. VCA Animal Hospitals in Canada, for example, provides stem cell therapy, also known as regenerative medicine, to assist dogs and cats’ bodies heal and replace damaged tissues.
  • The research institutes segment is predicted to develop at the fastest CAGR in the near future. This is due to increased R&D initiatives in regenerative medicine for animal health and developing clinical evidence.

Segmentation by Region

  • In 2022, North America had the biggest revenue share of more than 35%.
  • Asia Pacific is likely to grow at the quickest rate during the forecast period.
  • The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for Veterinary Regenerative Medicine.

Veterinary Regenerative Medicine Market Research

In 2022, North America had the biggest revenue share. This is due to increased knowledge of the benefits of regeneration therapy as well as the existence of major companies. For instance, prominent market participants such as Zoetis, VetStem, Vetherapy, Vetbiologics, and others are headquartered in the United States and pursue a variety of revenue-boosting strategies. This contributes to the company’s large market share.

The Asia Pacific region is expected to develop at the fastest CAGR during the projected period, owing to the growing number of facilities offering regenerative medicine services and the region’s burgeoning pet population. Increased animal expenditure and the development of veterinary healthcare facilities in the region are also expected to help to market expansion.

Key Highlights of the Report

The global Veterinary Regenerative Medicine Market is segmented by Therapy Type, Application Areas, End-User and region. The stem cells segment had the largest revenue share in 2022, and the orthopaedic disorders segment controls the majority of the income in the veterinary regenerative medicine industry. In addition, veterinary hospitals and clinics dominated the end-use segment, with North America leading the market growth.

Rising demand for improved and personalized treatment options, a growing emphasis on improving animal health, and technological advancements and constant research in the industry are the key drivers of the market. Furthermore, the key market constraints are high pricing associated with regenerative medicine therapies, regulatory difficulties and various approval processes, and a lack of awareness and understanding of regenerative medicine.

Nonetheless, North America will have the highest revenue share in 2022. This is owing to greater awareness of the benefits of regeneration therapy, as well as the presence of significant corporations. Furthermore, the Asia Pacific region is likely to grow at the quickest CAGR throughout the forecast period.

 What Elements Are Driving the Global Market for Veterinary Regenerative Medicine?

Several significant factors are driving the Veterinary Regenerative Medicine Market. There is an increasing desire in veterinary care for improved and individualized treatment alternatives. Pet owners are increasingly looking for novel ways to improve the health and well-being of their cherished pets. Furthermore, there is a growing emphasis on animal welfare, which has led to the acceptance of regenerative medicine as a means of providing effective and comprehensive treatment for animals. In addition, constant technical advances and research in the sector are pushing innovation and expanding the potential of regenerative therapies for animals, opening up new therapy and healing options..

What Are The Main Obstacles That The Global Veterinary Regenerative Medicine Market Faces?

While the Veterinary Regenerative Medicine Market is expanding, it is not without its challenges. One key impediment is the high expense of regenerative medicine treatments. These new medicines can be costly, leaving them out of reach for some pet owners. Furthermore, regulatory difficulties and varied approval processes for regenerative medicine products exist in different locations. This can create market entry obstacles and impede widespread adoption of these medicines. Moreover, there is a lack of understanding and awareness of regenerative medicine among veterinary practitioners and pet owners, which can have an impact on its adoption and utilization.

What Market Development Prospects Are There For Veterinary Regenerative Medicine Globally?

The Veterinary Regenerative Medicine Market offers numerous intriguing growth and development prospects. There is potential for regenerative medicine to be expanded into new veterinary uses. Orthopedics, wound healing, and dental care are just a few of the areas where regenerative therapies might help animals. Collaboration among veterinary clinics, research institutions, and industry actors can also help to speed the development and implementation of regenerative medicine. These stakeholders may improve the area by sharing knowledge, resources, and skills by working together. Additionally, there is a significant market opportunity in emerging economies, as more pet owners are looking for better treatment choices for their pets. This underserved market gives a chance for growth and reaching a larger client base.

Market Drivers

The global Veterinary Regenerative Medicine Market is driven by several factors. The following are the key drivers of the global Veterinary Regenerative Medicine Market:

Stem Cell Therapy is the Technology

There has been a boom in stem cell-based neuroscience research to address numerous neurological illnesses. Serum and bone marrow stem cells have been widely used in the isolation and generation of hematopoietic stem cells (HSCs) for application in regenerative medicine. Adult stem cells have garnered significant attention as a possible source of pluripotent stem cells for use in a variety of applications. Adult stem cells’ ability to divide or self-renew forever and develop all cell types of the organ from which they were triggered, potentially reconstructing the entire organ from a few cells.

Increasing Demand for Advanced and Personalized Veterinary Treatment Options

The expanding awareness and expectations of pet owners regarding the well-being and quality of life of their furry companions are driving the increasing need for improved and tailored treatment choices in veterinary care. Pet owners, like people, want more advanced and specialized treatment options for their beloved animals.

With advances in veterinary medicine, there is a better awareness of the distinct healthcare requirements of many animal species. Pet owners now anticipate tailored treatment regimens for their pets that address specific diseases and encourage optimal recovery and long-term health. They want access to cutting-edge therapies that are more effective and tailored than standard treatments.

Furthermore, as pet owners have a better understanding of potential treatment options, they are becoming more eager to pay in modern veterinarian care. They want their dogs to have access to the same medical discoveries and breakthroughs that humans do. This demand is driving the development and implementation of novel treatments in veterinary care, including as regenerative medicine, stem cell therapy, and precision medicine.

Market Restraints

The global Veterinary Regenerative Medicine Marketfaces some challenges that may hinder its growth. These include the following:

Affordability and Accessibility Issues

The Veterinary Regenerative Medicine Market confronts considerable constraints in terms of pricing and accessibility, limiting its mainstream adoption. The high costs connected with regenerative medicine treatments provide a challenge for many pet owners, limiting their capacity to obtain these advanced therapies for their beloved animals. The costs of research, development, manufacture, and specialized equipment all contribute to the overall cost of regenerative treatments.

Furthermore, the availability of regenerative medicine services may be limited to specific locations or veterinary clinics, making it difficult for pet owners in rural areas to receive these breakthrough treatments. This lack of accessibility can lead to a gap in the availability of regenerative therapies, denying certain pet owners the opportunity to investigate these potentially helpful treatments for their pets.

Opportunities

The global Veterinary Regenerative Medicine Marketoffers significant growth opportunities. These include the following:

Cutting-Edge Therapies for Animal Health

With the rapid advancement of regenerative medicine techniques, veterinarians now have the ability to give creative and successful therapies for a wide range of animal illnesses.

One important possibility exists in the realm of tissue engineering, where scientists are striving to create artificial organs, tissues, and biomaterials for use in veterinary medicine. These developments have enormous potential for treating numerous traumas, degenerative diseases, and congenital anomalies in animals. Regenerative medicine, by leveraging the potential of stem cells, growth hormones, and biomaterial scaffolds, offers the prospect of restoring damaged tissues and encouraging natural healing processes in animals.

Furthermore, regenerative medicine has the potential to provide new treatment choices for chronic and debilitating illnesses that were previously difficult to control. Conditions such as osteoarthritis, ligament injuries, and tendon damage, for example, can benefit tremendously from regenerative therapies such as stem cell therapy and platelet-rich plasma (PRP) treatments. These therapies have demonstrated encouraging effects in animals in terms of pain reduction, tissue regeneration, and general mobility and quality of life.

Competitive Landscape

Veterinary Regenerative Medicine Market Report

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Players

The global Veterinary Regenerative Medicine Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

  • VetStem, Inc.
  • Vetherapy
  • Boehringer Ingelheim International GmbH
  • Vetbiologics
  • Animal Cell Therapies, Inc.
  • Ardent
  • Zoetis
  • Dechra
  • ACell Inc. (Integra LifeSciences)
  • Enso Discoveries

These organizations prioritize product innovation, Disease Area expansion, and mergers and acquisitions to stay competitive.

The global Veterinary Regenerative Medicine Market’s key players continually seek to stay ahead by offering new Valve Types and developments.

In 2021, Crating Daeng, a TCH Group brand, collaborated with DHC, Japan’s leading manufacturer of food supplements, to address Thailand’s vitamin C needs.

In December 2021, CellVec, a veterinary cell therapy business, and Zoetis Inc. have teamed to explore gene-edited cell therapies for companion animals.

In November 2021, Aratana Therapeutics, Inc. has completed a crucial field effectiveness study for their osteoarthritis stem cell therapy for dogs. The study found a significant difference in mobility and pain levels between the treated and control groups.

In February 2021, IFFCO launches its nanotechnology-based products, nano nitrogen, nano zinc, and nano copper, for on-field trials as part of its efforts to reduce the usage of chemical fertilizers and enhance farmer income.

Summary of Key Findings

  • The primary opportunity in market expansion is cutting-edge therapies for animal health.
  • Market segmented by Therapy Type, Application Areas, End-User,  and region
  • the research institutes segment is expected to grow at the quickest CAGR in the near future.
  • The orthopedic diseases category generates the majority of the revenue in the veterinary regenerative medicine industry.
  • North America is leading market growth; the market is highly competitive with key players including VetStem, Inc.; Vetherapy; Boehringer Ingelheim International GmbH; Vetbiologics

Future Outlook

  • Increasing need for advanced veterinary therapies
  • Expanding use of regenerative medicine in animal health
  • Technological breakthroughs driving veterinary regenerative medicine innovation
  • Expansion of field research and development activities
  • Raising awareness of the benefits of regenerative medicine in veterinary practice
  • Industry collaborations and partnerships for product development
  • Increased funding in the development of regenerative medicine for animals
  • Market expansion to unexplored regions and rising economies
  • Regenerative medicine combined with other veterinary procedures
  • Consistent advances in stem cell research and veterinary medicine applications.

Segmentation

  • By Therapy Type
    • Cell-Based Therapies:
    • Stem Cell Therapy
    • Platelet-Rich Plasma (PRP) Therapy
    • Tissue Engineering
  • By Application Areas:
    • Orthopedic Disorders
    • Dental Disorders
    • Soft Tissue Injuries
    • Neurological Disorders
  • By End-User:
    • Veterinary Hospitals and Clinics
    • Research Institutions
    • Biotechnology Companies
  • By Region
    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • The U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East and Africa

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global Veterinary Regenerative Medicine Market
2.1.1. Global Veterinary Regenerative Medicine Market, By Therapy Type
2.1.2. Global Veterinary Regenerative Medicine Market, By Application Areas
2.1.3. Global Veterinary Regenerative Medicine Market, By End-User
2.1.4. Global Veterinary Regenerative Medicine Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Veterinary Regenerative Medicine Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Veterinary Regenerative Medicine Market Drivers
3.2.2. Veterinary Regenerative Medicine Market Restraints
3.2.3. Veterinary Regenerative Medicine Market Opportunities
3.2.4. Major Veterinary Regenerative Medicine Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Therapy Type
3.5.2. Application Areas
3.5.3. End-User
3.5.4. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global Veterinary Regenerative Medicine Market: Company Market Share, Value 2022
4.1.2. Global Veterinary Regenerative Medicine Market: Top 6 Company Market Share, Value 2022
4.1.3. Global Veterinary Regenerative Medicine Market: Top 3 Company Market Share, Value 2022
4.2. Global Veterinary Regenerative Medicine Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Therapy Type Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Therapy Type Matrix
4.7. Potential for New Players in the Global Veterinary Regenerative Medicine Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research Institutions in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Therapy Type Launch
6.5.5. Geographical Expansion
6.5.6. Gene Therapy:
7. Impact Analysis of COVID 19 and Russia – Ukraine War on Veterinary Regenerative Medicine Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Therapy Type Mix
7.2.4. Reduced Cell-Based Therapy Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global Veterinary Regenerative Medicine Market, By Therapy Type
8.1. Global Veterinary Regenerative Medicine Market Overview, By Therapy Type
8.1.1. Global Veterinary Regenerative Medicine Market Revenue Share, By Therapy Type, 2022 Vs 2030 (in %)
8.2. Cell-Based Therapy
8.2.1. Global Veterinary Regenerative Medicine Market, By CELL-BASED THERAPY, By Region, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for CELL-BASED THERAPY
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Stem Cell Therapy
8.3.1. Global Veterinary Regenerative Medicine Market, By STEM CELL THERAPY, By Region, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for STEM CELL THERAPY
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
8.4. Platelet-Rich Plasma (PRP) Therapy
8.4.1. Global Veterinary Regenerative Medicine Market, By Platelet-Rich Plasma (PRP) Therapy, By Region, 2017-2030 (US$ Mn)
8.4.2. Market Dynamics for Platelet-Rich Plasma (PRP) Therapy
8.4.2.1. Drivers
8.4.2.2. Restraints
8.4.2.3. Opportunities
8.4.2.4. Trends
8.5. Tissue Engineering
8.5.1. Global Veterinary Regenerative Medicine Market, By Tissue Engineering, By Region, 2017-2030 (US$ Mn)
8.5.2. Market Dynamics for Tissue Engineering
8.5.2.1. Drivers
8.5.2.2. Restraints
8.5.2.3. Opportunities
8.5.2.4. Trends
8.6. Gene Therapy:
8.6.1. Global Veterinary Regenerative Medicine Market, By Gene Therapy:, By Region, 2017-2030 (US$ Mn)
8.6.2. Market Dynamics for Gene Therapy:
8.6.2.1. Drivers
8.6.2.2. Restraints
8.6.2.3. Opportunities
8.6.2.4. Trends
9. Global Veterinary Regenerative Medicine Market, By Application Areas
9.1. Global Veterinary Regenerative Medicine Market Overview, By Application Areas
9.1.1. Global Veterinary Regenerative Medicine Market Revenue Share, By Application Areas, 2022 Vs 2030 (in %)
9.2. Orthopedic Disorders
9.2.1. Global Veterinary Regenerative Medicine Market, By Orthopedic Disorders, By Region, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for Orthopedic Disorders
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Dental Disorders
9.3.1. Global Veterinary Regenerative Medicine Market, By Dental Disorders, By Region, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for Dental Disorders
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Soft Tissue Injuries
9.4.1. Global Veterinary Regenerative Medicine Market, By Soft Tissue Injuries, By Region, 2017-2030 (US$ Mn)
9.4.2. Market Dynamics for Soft Tissue Injuries
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends
9.5. Neurological Disorders
9.5.1. Global Veterinary Regenerative Medicine Market, By Neurological Disorders, By Region, 2017-2030 (US$ Mn)
9.5.2. Market Dynamics for Neurological Disorders
9.5.2.1. Drivers
9.5.2.2. Restraints
9.5.2.3. Opportunities
9.5.2.4. Trends
10. Global Veterinary Regenerative Medicine Market, By End-User
10.1. Global Veterinary Regenerative Medicine Market Overview, By End-User
10.1.1. Global Veterinary Regenerative Medicine Market Revenue Share, By End-User,2022 Vs 2030 (in %)
10.2. Veterinary Hospitals and Clinics
10.2.1. Global Veterinary Regenerative Medicine Market, By Veterinary Hospitals and Clinics, By Region, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for Veterinary Hospitals and Clinics
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Research Institutions
10.3.1. Global Veterinary Regenerative Medicine Market, By Research Institutions, By Region, 2017-2030 (US$ Mn)
10.3.2. Market Dynamics for Research Institutions
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
10.4. Biotechnology Companies
10.4.1. Global Veterinary Regenerative Medicine Market, By Biotechnology Companies, By Region, 2017-2030 (US$ Mn)
10.4.2. Market Dynamics for Biotechnology Companies
10.4.2.1. Drivers
10.4.2.2. Restraints
10.4.2.3. Opportunities
10.4.2.4. Trends
11. Global Veterinary Regenerative Medicine Market, By Region
11.1. Global Veterinary Regenerative Medicine Market Overview, by Region
11.1.1. Global Veterinary Regenerative Medicine Market, By Region, 2022 vs 2030 (in%)
11.2. Therapy Type
11.2.1. Global Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2030 (US$ Mn)
11.3. Application Areas
11.3.1. Global Veterinary Regenerative Medicine Market, By Application Areas, 2017-2030 (US$ Mn)
11.4. End-User
11.4.1. Global Veterinary Regenerative Medicine Market, By End-User, 2017-2030 (US$ Mn)
12. North America Veterinary Regenerative Medicine Market Analysis
12.1. Overview
12.1.1. Market Dynamics for North America
12.1.1.1. Drivers
12.1.1.2. Restraints
12.1.1.3. Opportunities
12.1.1.4. Trends
12.2. North America Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2030(US$ Mn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. North America Veterinary Regenerative Medicine Market, By Application Areas, 2017-2030(US$ Mn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. North America Veterinary Regenerative Medicine Market, By End-User, 2017-2030(US$ Mn)
12.4.1. Overview
12.4.2. SRC Analysis
12.5. North America Veterinary Regenerative Medicine Market, by Country, 2017-2030(US$ Mn)
12.5.1. North America Veterinary Regenerative Medicine Market, by Country, 2022 Vs 2030 (in%)
12.5.2. U.S.
12.5.3. Canada
12.5.4. Mexico
13. Europe Veterinary Regenerative Medicine Market Analysis
13.1. Overview
13.1.1. Market Dynamics for North America
13.1.1.1. Drivers
13.1.1.2. Restraints
13.1.1.3. Opportunities
13.1.1.4. Trends
13.2. Europe Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2030(US$ Mn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. Europe Veterinary Regenerative Medicine Market, By Application Areas, 2017-2030(US$ Mn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. Europe Veterinary Regenerative Medicine Market, By End-User, 2017-2030(US$ Mn)
13.4.1. Overview
13.4.2. SRC Analysis
13.5. Europe Veterinary Regenerative Medicine Market, by Country, 2017-2030 (US$ Mn)
13.5.1. Europe Veterinary Regenerative Medicine Market, by Country, 2022 Vs 2030 (in%)
13.5.2. UK
13.5.3. France
13.5.4. Germany
13.5.5. Italy
13.5.6. Spain
13.5.7. Benelux
13.5.8. Russia
13.5.9. Rest of Europe
14. Asia Pacific Veterinary Regenerative Medicine Market Analysis
14.1. Overview
14.1.1. Market Dynamics for North America
14.1.1.1. Drivers
14.1.1.2. Restraints
14.1.1.3. Opportunities
14.1.1.4. Trends
14.2. Asia Pacific Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2030(US$ Mn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Asia Pacific Veterinary Regenerative Medicine Market, By Application Areas, 2017-2030(US$ Mn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Asia Pacific Veterinary Regenerative Medicine Market, By End-User, 2017-2030(US$ Mn)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. Asia Pacific Veterinary Regenerative Medicine Market, by Country, 2017-2030 (US$ Mn)
14.5.1. Asia Pacific Veterinary Regenerative Medicine Market, by Country, 2022 Vs 2030 (in%)
14.5.2. China
14.5.3. Japan
14.5.4. India
14.5.5. South Korea
14.5.6. South East Asia
14.5.7. Rest of Asia Pacific
15. Latin America Veterinary Regenerative Medicine Market Analysis
15.1. Overview
15.1.1. Market Dynamics for North America
15.1.1.1. Drivers
15.1.1.2. Restraints
15.1.1.3. Opportunities
15.1.1.4. Trends
15.2. Latin America Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2030(US$ Mn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Latin America Veterinary Regenerative Medicine Market, By Application Areas, 2017-2030(US$ Mn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Latin America Veterinary Regenerative Medicine Market, By End-User, 2017-2030(US$ Mn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Latin America Veterinary Regenerative Medicine Market, by Country, 2017-2030 (US$ Mn)
15.5.1. Latin America Veterinary Regenerative Medicine Market, by Country, 2022 Vs 2030 (in%)
15.5.2. Brazil
15.5.3. Argentina
15.5.4. Rest of Latin America
16. Middle East Veterinary Regenerative Medicine Market Analysis
16.1. Overview
16.1.1. Market Dynamics for North America
16.1.1.1. Drivers
16.1.1.2. Restraints
16.1.1.3. Opportunities
16.1.1.4. Trends
16.2. Middle East Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2030(US$ Mn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Middle East Veterinary Regenerative Medicine Market, By Application Areas, 2017-2030(US$ Mn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Middle East Veterinary Regenerative Medicine Market, By End-User, 2017-2030(US$ Mn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Middle East Veterinary Regenerative Medicine Market, by Country, 2017-2030 (US$ Mn)
16.5.1. Middle East Veterinary Regenerative Medicine Market, by Country, 2022 Vs 2030 (in%)
16.5.2. UAE
16.5.3. Saudi Arabia
16.5.4. Rest of Middle East
17. Africa Veterinary Regenerative Medicine Market Analysis
17.1. Overview
17.1.1. Market Dynamics for North America
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. Africa Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2030(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Africa Veterinary Regenerative Medicine Market, By Application Areas, 2017-2030(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Africa Veterinary Regenerative Medicine Market, By End-User, 2017-2030(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Africa Veterinary Regenerative Medicine Market, by Country, 2017-2030 (US$ Mn)
17.5.1. Middle East Veterinary Regenerative Medicine Market, by Country, 2022 Vs 2030 (in%)
17.5.2. South Africa
17.5.3. Egypt
17.5.4. Rest of Africa
18. Company Profiles
18.1. VetStem, Inc.
18.1.1. Company Overview
18.1.2. Therapy Types/Services Portfolio
18.1.3. Geographical Presence
18.1.4. SWOT Analysis
18.1.5. Financial Summary
18.1.5.1. Market Revenue and Net Profit (2019-2022)
18.1.5.2. Business Segment Revenue Analysis
18.1.5.3. Geographical Revenue Analysis
18.2. Vetherapy
18.3. Boehringer Ingelheim International GmbH
18.4. Vetbiologics
18.5. Animal Cell Therapies, Inc.
18.6. Ardent
18.7. Zoetis
18.8. Dechra
18.9. ACell Inc. (Integra LifeSciences)
18.10. Enso Discoveries
19. Research Methodology
19.1. Research Methodology
19.2. Veterinary Hospitals and Clinics – Secondary Research
19.3. Veterinary Hospitals and ClinicsI – Data Modelling
19.3.1. Company Share Analysis Model
19.3.2. Revenue Based Modelling
19.4. Veterinary Hospitals and ClinicsII – Primary Research
19.5. Research Limitations
19.5.1. Assumptions

List of Figures
FIG. 1 Global Veterinary Regenerative Medicine Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Veterinary Regenerative Medicine Market Segmentation
FIG. 4 Global Veterinary Regenerative Medicine Market, By Therapy Type, 2022 (US$ Mn)
FIG. 5 Global Veterinary Regenerative Medicine Market, By Application Areas, 2022 (US$ Mn)
FIG. 6 Global Veterinary Regenerative Medicine Market, By End-User, 2022 (US$ Mn)
FIG. 7 Global Veterinary Regenerative Medicine Market, by Geography, 2022 (US$ Mn)
FIG. 8 Attractive Investment Proposition, By Therapy Type, 2022
FIG. 9 Attractive Investment Proposition, By Application Areas, 2022
FIG. 10 Attractive Investment Proposition, By End-User, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Veterinary Regenerative Medicine Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Veterinary Regenerative Medicine Market Manufacturers, 2022
FIG. 14 Global Veterinary Regenerative Medicine Market Value Contribution, By Therapy Type, 2022 & 2030 (Value %)
FIG. 15 Global Veterinary Regenerative Medicine Market, by CELL-BASED THERAPY, Value, 2017-2030 (US$ Mn)
FIG. 16 Global Veterinary Regenerative Medicine Market, by STEM CELL THERAPY, Value, 2017-2030 (US$ Mn)
FIG. 17 Global Veterinary Regenerative Medicine Market, by Platelet-Rich Plasma (PRP) Therapy, Value, 2017-2030 (US$ Mn)
FIG. 18 Global Veterinary Regenerative Medicine Market, by Tissue Engineering, Value, 2017-2030 (US$ Mn)
FIG. 19 Global Veterinary Regenerative Medicine Market, by Gene Therapy:, Value, 2017-2030 (US$ Mn)
FIG. 20 Global Veterinary Regenerative Medicine Market Value Contribution, By Application Areas, 2022 & 2030 (Value %)
FIG. 21 Global Veterinary Regenerative Medicine Market, by Orthopedic Disorders, Value, 2017-2030 (US$ Mn)
FIG. 22 Global Veterinary Regenerative Medicine Market, by Dental Disorders, Value, 2017-2030 (US$ Mn)
FIG. 23 Global Veterinary Regenerative Medicine Market, by Soft Tissue Injuries, Value, 2017-2030 (US$ Mn)
FIG. 24 Global Veterinary Regenerative Medicine Market, by Neurological Disorders, Value, 2017-2030 (US$ Mn)
FIG. 25 Global Veterinary Regenerative Medicine Market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 26 Global Veterinary Regenerative Medicine Market, by Veterinary Hospitals and Clinics, Value, 2017-2030 (US$ Mn)
FIG. 27 Global Veterinary Regenerative Medicine Market, by Research Institutions, Value, 2017-2030 (US$ Mn)
FIG. 28 Global Veterinary Regenerative Medicine Market, by Biotechnology Companies, Value, 2017-2030 (US$ Mn)
FIG. 29 North America Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 30 U.S. Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 31 Canada Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 32 Mexico Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 33 Europe Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 34 Germany Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 35 France Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 36 U.K. Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 37 Italy Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 38 Spain Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 39 Benelux Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 40 Russia Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 41 Rest of Europe Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 42 Asia Pacific Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 43 China Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 44 Japan Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 45 India Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 46 South Korea Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 47 South-East Asia Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 48 Rest of Asia Pacific Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 49 Latin America Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 50 Brazil Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 51 Argentina Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 52 Rest of Latin America Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 53 Middle East Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 54 UAE Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 55 Saudi Arabia Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 56 Rest of Middle East Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 57 Africa Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 58 South Africa Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 59 Egypt Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)
FIG. 60 Rest of Africa Veterinary Regenerative Medicine Market, 2017-2030 (US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global Veterinary Regenerative Medicine Market
TABLE 2 Global Veterinary Regenerative Medicine Market: Drivers Impact Analysis
TABLE 3 Global Veterinary Regenerative Medicine Market: Market Restraints Impact Analysis
TABLE 4 Global Veterinary Regenerative Medicine Market, by Competitive Benchmarking, 2022
TABLE 5 Global Veterinary Regenerative Medicine Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Veterinary Regenerative Medicine Market, by Key Strategies Analysis, 2022
TABLE 7 Global Veterinary Regenerative Medicine Market, by CELL-BASED THERAPY, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Veterinary Regenerative Medicine Market, by CELL-BASED THERAPY, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Veterinary Regenerative Medicine Market, by STEM CELL THERAPY, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Veterinary Regenerative Medicine Market, by STEM CELL THERAPY, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Veterinary Regenerative Medicine Market, by Platelet-Rich Plasma (PRP) Therapy, By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Veterinary Regenerative Medicine Market, by Platelet-Rich Plasma (PRP) Therapy, By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Veterinary Regenerative Medicine Market, by Tissue Engineering, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Veterinary Regenerative Medicine Market, by Tissue Engineering, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Veterinary Regenerative Medicine Market, by Gene Therapy:, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Veterinary Regenerative Medicine Market, by Gene Therapy:, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Veterinary Regenerative Medicine Market, by Orthopedic Disorders, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Veterinary Regenerative Medicine Market, by Orthopedic Disorders, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global Veterinary Regenerative Medicine Market, by Dental Disorders, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global Veterinary Regenerative Medicine Market, by Dental Disorders, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global Veterinary Regenerative Medicine Market, by Soft Tissue Injuries, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global Veterinary Regenerative Medicine Market, by Soft Tissue Injuries, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global Veterinary Regenerative Medicine Market, by Neurological Disorders, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global Veterinary Regenerative Medicine Market, by Neurological Disorders, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global Veterinary Regenerative Medicine Market, by Veterinary Hospitals and Clinics, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global Veterinary Regenerative Medicine Market, by Veterinary Hospitals and Clinics, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global Veterinary Regenerative Medicine Market, by Research Institutions, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global Veterinary Regenerative Medicine Market, by Research Institutions, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global Veterinary Regenerative Medicine Market, by Biotechnology Companies, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global Veterinary Regenerative Medicine Market, by Biotechnology Companies, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 32 Global Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 33 Global Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 34 Global Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 35 Global Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 36 Global Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 37 Global Veterinary Regenerative Medicine Market, by Region, 2017-2022 (US$ Mn)
TABLE 38 Global Veterinary Regenerative Medicine Market, by Region, 2023-2030 (US$ Mn)
TABLE 39 North America Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 40 North America Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 41 North America Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 42 North America Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 43 North America Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 44 North America Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 45 North America Veterinary Regenerative Medicine Market, by Country, 2017-2022 (US$ Mn)
TABLE 46 North America Veterinary Regenerative Medicine Market, by Country, 2023-2030 (US$ Mn)
TABLE 47 United States Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 48 United States Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 49 United States Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 50 United States Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 51 United States Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 52 United States Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 53 Canada Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 54 Canada Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 55 Canada Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 56 Canada Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 57 Canada Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 58 Canada Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 59 Mexico Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 60 Mexico Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 61 Mexico Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 62 Mexico Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 63 Mexico Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 64 Mexico Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 65 Europe Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 66 Europe Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 67 Europe Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 68 Europe Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 69 Europe Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 70 Europe Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 71 Europe Veterinary Regenerative Medicine Market, by Country, 2017-2022 (US$ Mn)
TABLE 72 Europe Veterinary Regenerative Medicine Market, by Country, 2023-2030 (US$ Mn)
TABLE 73 Germany Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 74 Germany Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 75 Germany Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 76 Germany Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 77 Germany Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 78 Germany Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 79 France Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 80 France Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 81 France Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 82 France Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 83 France Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 84 France Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 85 United Kingdom Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 86 United Kingdom Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 87 United Kingdom Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 88 United Kingdom Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 89 United Kingdom Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 90 United Kingdom Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 91 Italy Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 92 Italy Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 93 Italy Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 94 Italy Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 95 Italy Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 96 Italy Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 97 Spain Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 98 Spain Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 99 Spain Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 100 Spain Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 101 Spain Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 102 Spain Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 103 Benelux Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 104 Benelux Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 105 Benelux Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 106 Benelux Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 107 Benelux Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 108 Benelux Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 109 Russia Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 110 Russia Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 111 Russia Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 112 Russia Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 113 Russia Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 114 Russia Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 115 Rest of Europe Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 116 Rest of Europe Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 117 Rest of Europe Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 118 Rest of Europe Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 119 Rest of Europe Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 120 Rest of Europe Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 121 Asia Pacific Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 122 Asia Pacific Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 123 Asia Pacific Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 124 Asia Pacific Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 125 Asia Pacific Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 126 Asia Pacific Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 127 China Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 128 China Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 129 China Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 130 China Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 131 China Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 132 China Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 133 Japan Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 134 Japan Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 135 Japan Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 136 Japan Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 137 Japan Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 138 Japan Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 139 India Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 140 India Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 141 India Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 142 India Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 143 India Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 144 India Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 145 South Korea Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 146 South Korea Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 147 South Korea Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 148 South Korea Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 149 South Korea Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 150 South Korea Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 151 South-East Asia Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 152 South-East Asia Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 153 South-East Asia Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 154 South-East Asia Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 155 South-East Asia Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 156 South-East Asia Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 157 Rest of Asia Pacific Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 158 Rest of Asia Pacific Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 159 Rest of Asia Pacific Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 160 Rest of Asia Pacific Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 161 Rest of Asia Pacific Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 162 Rest of Asia Pacific Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 163 Latin America Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 164 Latin America Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 165 Latin America Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 166 Latin America Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 167 Latin America Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 168 Latin America Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 169 Brazil Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 170 Brazil Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 171 Brazil Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 172 Brazil Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 173 Brazil Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 174 Brazil Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 175 Argentina Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 176 Argentina Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 177 Argentina Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 178 Argentina Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 179 Argentina Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 180 Argentina Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 181 Rest of Latin America Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 182 Rest of Latin America Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 183 Rest of Latin America Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 184 Rest of Latin America Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 185 Rest of Latin America Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 186 Rest of Latin America Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 187 Middle East Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 188 Middle East Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 189 Middle East Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 190 Middle East Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 191 Middle East Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 192 Middle East Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 193 UAE Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 194 UAE Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 195 UAE Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 196 UAE Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 197 UAE Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 198 UAE Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 199 Saudi Arabia Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 200 Saudi Arabia Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 201 Saudi Arabia Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 202 Saudi Arabia Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 203 Saudi Arabia Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 204 Saudi Arabia Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 205 Rest of Middle East Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 206 Rest of Middle East Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 207 Rest of Middle East Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 208 Rest of Middle East Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 209 Rest of Middle East Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 210 Rest of Middle East Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 211 Africa Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 212 Africa Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 213 Africa Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 214 Africa Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 215 Africa Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 216 Africa Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 217 South Africa Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 218 South Africa Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 219 South Africa Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 220 South Africa Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 221 South Africa Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 222 South Africa Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 223 Egypt Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 224 Egypt Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 225 Egypt Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 226 Egypt Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 227 Egypt Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 228 Egypt Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)
TABLE 229 Rest of Africa Veterinary Regenerative Medicine Market, By Therapy Type, 2017-2022 (US$ Mn)
TABLE 230 Rest of Africa Veterinary Regenerative Medicine Market, By Therapy Type, 2023-2030 (US$ Mn)
TABLE 231 Rest of Africa Veterinary Regenerative Medicine Market, By Application Areas, 2017-2022 (US$ Mn)
TABLE 232 Rest of Africa Veterinary Regenerative Medicine Market, By Application Areas, 2023-2030 (US$ Mn)
TABLE 233 Rest of Africa Veterinary Regenerative Medicine Market, By End-User, 2017-2022 (US$ Mn)
TABLE 234 Rest of Africa Veterinary Regenerative Medicine Market, By End-User, 2023-2030 (US$ Mn)

What is the current End-User of the worldwide Veterinary Regenerative Medicine Market?

In 2022, the global Veterinary Regenerative Medicine Market is expected to be worth USD 284.5 million.

What is the predicted growth rate of the Veterinary Regenerative Medicine Market between 2023 and 2030?

The Veterinary Regenerative Medicine Market is estimated to increase at a CAGR of 13.80% between 2023 and 2030, reaching USD 800.2 Million in 2030.

Which segment has the most market share in terms of Therapy type ?

The stem cell category had the highest revenue share in 2022

Which Application area segment governs the market demand for Veterinary Regenerative Medicine?

The orthopedic diseases category generates the majority of the revenue in the veterinary regenerative medicine industry.

Which End-User segment is predicted to grow at the highest rate over the forecast period?

The research institutes segment is expected to grow at the quickest CAGR in the near future.

Qatar Dental Care Market

Published:
Report ID: 30608

Neuromyelitis Optica Spectrum Disorder (NMOSD) Market

Published:
Report ID: 33712

Tracheitis Treatment Market

Published:
Report ID: 33694

Neuralgia Treatment Market

Published:
Report ID: 33681

Clostridioides Difficile (C. diff) Treatment Market

Published:
Report ID: 33667

Hepatic Encephalopathy Market

Published:
Report ID: 33664

Sphingosine-1-Receptor Modulators Drugs Market

Published:
Report ID: 33649

Guidewires Market

Published:
Report ID: 6790

3D Printing for Personalized Healthcare Market

Published:
Report ID: 33603

Neuromyelitis Optica Therapy Market

Published:
Report ID: 33583

In Vitro Diagnostic (IVD) Kit Market

Published:
Report ID: 33580

North America Medical Headgears Market

Published:
Report ID: 33554

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN